Cephacetril — Competitive Intelligence Brief

Cephacetril (cefacetrile) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: cefacetrile. Area: Metabolic.

unknown cefacetrile Penicillin-binding protein 1A Metabolic

Target snapshot

Cephacetril (cefacetrile). Cephacetril works by blocking the enzymes that bacteria need to build their cell walls, ultimately leading to the death of the bacteria.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Cephacetril TARGET	cefacetrile		unknown	cefacetrile	Penicillin-binding protein 1A
Rocephin	ceftriaxone	Generic (originally Roche)	marketed	Cephalosporin antibiotic (third-generation)	Alpha-synuclein, D-amino-acid oxidase, Penicillin-binding protein 1A	1984-12-21
Bl-S786R	CEFORANIDE		marketed	ceforanide	Bacterial penicillin-binding protein, Penicillin-binding protein 1A	1984-01-01
Cefobid	CEFOPERAZONE		marketed	Cephalosporin Antibacterial	Bacterial penicillin-binding protein, Penicillin-binding protein 1A	1982-01-01
flucloxacillin	flucloxacillin	Karlstad University	marketed		Matrix metalloproteinase-9, Androgen receptor, Penicillin-binding protein 1A
Ceftazidim	Ceftazidim	Tel-Aviv Sourasky Medical Center	marketed		Penicillin-binding protein 1A, Penicillin-binding protein 1B, Peptidoglycan synthase FtsI
Phenoxymethylpenicillin	Phenoxymethylpenicillin	Katarina Hedin	marketed		Bacterial penicillin-binding protein, Penicillin-binding protein 1A

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (cefacetrile class)

1. · 1 drug in this class